welcome to our Press room
We have gathered the content you need to share your storiesPress releases
Odense-based Velatir raises €5 million to help European companies scale AI
Just six months after launching, Odense-based AI infrastructure company Velatir has raised €5 million (DKK 37 million) from a group of leading Nordic investors. The funding will support the company’s rapid European expansion and help accelerate its mission of enabling businesses to adopt AI securely and at scale.
Odense-based Vertanical secures German approval, opening access to Europe’s largest healthcare market
Vertanical’s cannabis-based pain treatment Exilby® has received marketing authorization in Germany, marking an important milestone for both the company and Funen’s growing medical cannabis ecosystem. The approval highlights how research, production capabilities, and industry collaboration help bring new treatments to patients across Europe.
CrossingBio: The Latest SDU Spinout Aiming to Transform Liver Fibrosis Treatment
CrossingBio is the newest addition to the growing portfolio of life science spinouts from the University of Southern Denmark (SDU). The company is developing a new therapeutic approach for liver fibrosis, a condition affecting millions of people worldwide and still difficult to treat effectively.
LOGOS
Download
PEOPLE
Download
Let’s get in touch
Mette Falk
Marketing Manager - Invest in Odense
As the Marketing Manager for Invest in Odense, I am passionate about showcasing the strengths and potential our city holds. With a background steeped in marketing and a deep affection for the city of Odense, I am excited to lead initiatives that position Odense as a global hub within our specific strongholds.
+45 2368 8982
mefal@odense.dk
Connect
Latest News from the City of Odense
CrossingBio: The Latest SDU Spinout Aiming to Transform Liver Fibrosis Treatment
CrossingBio is the newest addition to the growing portfolio of life science spinouts from the University of Southern Denmark (SDU). The company is developing a new therapeutic approach for liver fibrosis, a condition affecting millions of people worldwide and still difficult to treat effectively.
Financial Times highlights Odense Robotics StartUp Fund among Europe’s leading startup hubs
The British newspaper Financial Times has published its annual ranking of Europe’s leading startup hubs and accelerator programmes. Once again, Odense Robotics StartUp Fund is included on the list, and stands out as the only robotics-focused incubator to be recognised.
Velatir raises DKK 10 million in funding round to give European companies control over AI use
The Odense-based AI startup Velatir has raised DKK 10 million in pre-seed funding to help European companies scale their use of artificial intelligence with greater transparency, governance and control.
The investment round was led by Ugly Duckling Ventures, with participation from Norrsken.